Data / Drug companies / Nebivolol
Nebivolol: 21 companies and 76 products in the FDA NDC directory
Nebivolol is listed in the FDA National Drug Code Directory by 21 companies, with 76 products in commercial distribution. 76 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on May 14, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 21
- Products
- 76
- Generic (ANDA) products
- 76 (100.0%)
- Application numbers
- 9
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list nebivolol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 5 | tablet | Generic drugs (ANDA) | October 1, 2024 |
| Ani Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | September 17, 2021 |
| Ascend Laboratories, LLC | 4 | tablet | Generic drugs (ANDA) | September 16, 2021 |
| Aurobindo Pharma Limited | 4 | tablet | Generic drugs (ANDA) | December 17, 2021 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | December 29, 2017 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | February 14, 2022 |
| Bryant Ranch Prepack | 4 | tablet | Generic drugs (ANDA) | October 1, 2024 |
| Cadila Pharmaceuticals Limited | 4 | tablet | Generic drugs (ANDA) | December 29, 2017 |
| Camber Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | September 17, 2021 |
| Golden State Medical Supply, Inc. | 4 | tablet | Generic drugs (ANDA) | April 16, 2015 |
| Lifestar Pharma LLC | 4 | tablet | Generic drugs (ANDA) | November 14, 2022 |
| Macleods Pharmaceuticals Limited | 4 | tablet | Generic drugs (ANDA) | January 29, 2025 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | May 14, 2026 |
| Modavar Pharmaceuticals LLC | 4 | tablet | Generic drugs (ANDA) | December 29, 2017 |
| NorthStar RxLLC | 4 | tablet | Generic drugs (ANDA) | July 14, 2025 |
| Novadoz Pharmaceuticals LLC | 4 | tablet | Generic drugs (ANDA) | October 1, 2024 |
| Solco Healthcare US, LLC | 4 | tablet | Generic drugs (ANDA) | February 14, 2022 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | April 28, 2026 |
| American Health Packaging | 2 | tablet | Generic drugs (ANDA) | September 7, 2022 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | October 30, 2024 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 17, 2021 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 76 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 76 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 76 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.